Atlas Trials

Study to Evaluate the Safety and Efficacy of the 10 GE Xenokidney in Patients With ESRD

Clinical trial NCT06878560 · RECRUITING

Trial details

NCT number
NCT06878560
Sponsor
United Therapeutics
Status
RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
ESRD (End-Stage Renal Disease)Kidney TransplantationXenotransplantation
Start date
2025-10-29
Primary completion
2028-10-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.